What happens when a young man inherits a fortune but then uses his inheritance to challenge the systems which created it in the first place? We may be about to find out. The sale of leading German pharmaceuticals company Schwarz Pharma in 2006 changed the life of Antonis Schwarz, 16 years old at the time. He talks to Alliance editor, Charles Keidan, about his philanthropic vision and what motivates him to keep driving forward. Alliance issue: Diaspora Philanthropy; March 2018, Volume 23, Number 2.